Radical Prostatectomy as a First-Line Treatment in Patients with Initial PSA  >20 ng/mL

Table 3

Oncological outcome at the 10th year after surgery.

Patient group	BCR-free survival		Overall survival		Cancer-specific survival
	% Censored cases	KM estimates (10th year)	% Censored cases	KM estimates (10th year)	% Censored cases	KM estimates (10th year)
A (PSA ≤20 ng/mL)	84.7%	79.6%	87.8%	71.7%	95.4%	87.9%
B (PSA >20 ng/mL)	51.4%	20.7%	83.8%	55.7%	86.5%	65.0%
𝑃 value	< 0.001		0.172		0.010